Eczema and endless itching?

Local Clinical Trials are enrolling now.

Those who qualify may receive*:

  • Compensation for travel
  • No-cost study medication

If you are eligible and choose to participate, you may receive clinical trial related care and medical advice.

Ready to get started? Click Here.

Eczema, also known as atopic dermatitis is not just a cosmetic disease.

  • It is a chronic skin condition that causes patches of red, itchy, dry skin to appear on various parts of the body.
  • When someone has moderate or severe eczema, it can cause intense pain, itchiness, and skin cracking. Eczema can flare periodically, especially when exposed to certain triggers such as cold or dry air and contact with irritants, including rough fabrics and chemicals such as perfumes or dyes.
  • Moderate to severe eczema can interfere with everyday life, causing absences at work days and missed social activities. And, eczema patches on visible areas of the body, such as the face, neck, and hands may cause embarrassment.

Current treatments for eczema do not work well for everyone. That’s why local doctors are conducting research studies and evaluating study medications that are not available from regular doctors.

You may qualify for clinical trials. But don’t delay — space is limited!

* In a clinical trial, the participants may receive investigational product or may receive an inactive substance, or placebo, depending on the design of the clinical trial. Participants receive clinical trial related care and medical advice for the duration of the trial. Reasonable compensation will be made for travel and the length of the trial may vary.

Ready to get started?

Click Here.

How does it work?

1

Tell us a little bit about yourself

2

Answer some questions about your health

3

We will connect you to available studies in your area

Just takes a few minutes

AcurianHealth

AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.